WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 202
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 25'155  25'027  24'896  24'763  24'631  22'840  20'194  17'372 
Births 360  359  358  356  354  409  421  349 
Surviving infants 353  352  350  348  346  391  407  338 
Pop. less than 5 years 1'747  1'733  1'710  1'691  1'691  1'983  1'950  1'586 
Pop. less than 15 years 5'325  5'365  5'400  5'435  5'484  5'943  5'406  6'302 
Female 15-49 years 6'695  6'695  6'676  6'645  6'611  6'073  5'750  4'619 

Number of reported cases

(Click for retrospective incidence data for Democratic People's Republic of Korea (the))
Diphtheria
ChartChart
  18 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
 
Mumps
ChartChart
  11  66 
Pertussis
ChartChart
  13  304  58 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  537 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Democratic People's Republic of Korea (the))
Vaccine year result method % card seen                                                
BCG 2007  97  EPI   100  97  98  98  98  98  82  99  50 
DTP1 2007  94  EPI   100  97  94  94  97  95  82 
DTP3 2007  92  EPI   100  96  93  93  96  94  80  98  50 
DTP4         
IPV1          99 
HepB_BD          97  99  99  99  99 
HepB3 2007  92  EPI   100  96  93  96  94  30 
Hib3          96  93  96 
JapEnc         
MCV1          98  99  99  99  99  92  98  29 
MCV2          97  99  99  99  99 
PCV1         
PCV3         
Pol3 2007  99  EPI   100  99  99  99  99  99  98  99  50 
Rota1         
RotaC         
Rubella1         
TT2plus 1999  74  MICS   99  98  97  99  99  99  84  98 
PAB         
VAD1          98  99  99*  99*  99* 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Democratic People's Republic of Korea (the))
BCG
ChartChart
  98  98  98  98  78  99  50 
DTP1
ChartChart
  94  94  97  95  61  98  74 
DTP3
ChartChart
  93  93  96  94  56  98  50 
HepB3
ChartChart
  93  93  96  94 
HepB_BD
ChartChart
  99  99  99  99 
Hib3
ChartChart
  93  93  32 
MCV1
ChartChart
  99  99  99  99  78  98  29 
MCV2
ChartChart
  99  99  99  99 
PAB
ChartChart
  93  93  93  93  81  90 
PCV3
ChartChart
 
Pol3
ChartChart
  99  99  99  99  93  99  50 
RotaC
ChartChart
 

Number of districts in the country 210  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
IPV 14 weeks; Yes
Measles 9, 15 months; Yes
OPV 6, 10, 14 weeks; Yes
Td 3, 4 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 210  209  208         

System performance

Total Nº districts in country number 210  209  208  208  208  208  210 
Nº districts with DTP3 coverage >=80% number 210  209  208  208  208  208  210 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 210  209  208  208  208  208  210 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 48  48  50    27  30  35 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.